News

Sodium glucose co-transporter 2 (SGLT2) inhibitors have already remade the diabetes drug market. Now competition for new cardiac and renal indications is heating up among three of the main drugs in the class: Janssen’s Invokana (canagliflozin), AstraZeneca’s Farxiga (dapagliflozin), and Eli Lilly/Boehringer-Ingelheim’s Jardiance (empagliflozin).

Emergency use authorization granted for CareStart point-of-care kit.

Some “don’t give a damn about their fellow man.” But in this first of four-part video series, the Johns Hopkins professor, former chief medical and scientific officer of the American Cancer Society, and MHE Editorial Advisory Board member is encouraged by diversity among protestors and the broadening of the efforts to tackle disparities of all kinds. “I think this is a long-term effort.”

The pharma maker aims to make the treatment available to the most vulnerable populations by December.

Simponi Aria is now approved to to treat patients 2 years and older with active polyarticular juvenile Idiopathic arthritis (pJIA) and psoriatic arthritis (PsA).

Johnson & Johnson pauses trial, Pfizer wants to enroll teens, and fewer Americans are willing to be vaccinated. Here's a roundup of today's news about COVID-19 vaccines.

Council for Affordable Quality Healthcare, Inc.'s solution will facilitate how health plans, Medicaid agencies and third-party apps find and share technology connections to provide consumers greater access to their healthcare data.

There's a possibility the flu shot can help protect those who receive it from COVID-19.

Central obesity may be especially unhealthy for people with the inflammatory condition that affects the spine.

Research documents that the disease affects men and women differently.

COVID-19 has accelerated the need to attract and retain patients, yet 38% of health system leaders aren't confident about their visibility into leakage.

The benefits space is changing and there is currently a shift to “enviable benefits” - ones that go beyond traditional health and retirement coverage. Many companies, especially those still doing well during the economic downturn, have ramped up benefits communication about existing support programs such as telemedicine, financial well-being and childcare.

In an interview with Axios about the first political editorial in the journal's history, Editor-in-Chief Eric Rubin says it is not an endorsement of Joe Biden but sends the message to "simply throw the bums out" and not vote for Donald Trump.

Even as many industries continue to suffer devastating setbacks due to the COVID-19 pandemic, one sector that has enjoyed an “embarrassment of profits” is health insurance.

David Lareau, CEO of Medicomp Systems, says this delay will mean ongoing challenges in access to accurate, complete data—which is more important now than ever before.

Results show an electorate deeply divided by age, gender, and partisanship.

In this week’s episode of Tuning Into the C-Suite, MHE's Briana Contreras spoke with Denise Basow, president and CEO of Clinical Effectiveness at Wolters Kluwer. Briana and Basow discussed the importance of uniting prescribers and pharmacists at the point of care and how this form of care can create more efficient and effective operations within health systems.

Experts discuss the falsehoods and half-baked ideas that are in circulation about COVID-19 transmission, treatment and equivalence to the flu.

The Max Cure Foundation is urging a dramatic reduction of toxic chemicals in the environment and within consumer products to reduce the number of children diagnosed with cancer.

The combination therapy of Opdivo plus Yervoy will treat the cancer caused by inhaling asbestos fibers.

The recall is attributed to higher levels of the carcinogenic ingredient NDMA than are allowed.

Insights from MGMA’s data report tracks key performance indicators and best practices for optimizing patient access and sustaining financial viability through the pandemic.

Lindsay Engle, Medicare Expert at MedicareFAQ, clears more of the air on what Medicare’s future could possibly look like under either presidential candidate's reign.

Without changes to next year's Medicare fee schedule, physician payment would be reduced by almost 11%. says the AMA.

Battling racial bias in the workplace. How implementing an inclusion, diversity, equity and accessibility training initiative can lead to better results in racial disparities within healthcare and beyond.

"If the president can get infected in the protected bubble he lives in, anyone can."

An immunotherapy combination gets a third thoracic indication; another potential indication for an SGLT2 inhibitor.

In recent decades, many companies have adopted the maxim, “Do what you do best, and outsource the rest.” From the ability to focus on the core of their business to gaining outside expertise to boosting their quality of service, there are many reasons outsourcing may be appealing to an organization.

Second study shows minority children are half as likely to have surgery as white children.